Dr. Aarshi R. Vipani, MD

Dr. Vipani practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Vipani's NPI, 1316392335, was assigned on April 27, 2016. Dr. Vipani graduated from Albany Medical College in 2016. Dr. Vipani holds California license A155894.

Dr. Vipani's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Vipani's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Vipani is also affiliated with Torrance Memorial Medical Center. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Vipani to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vipani practices, 4 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Vipani's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Vipani is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Vipani is licensed in California.

Dmand AI lists fatty liver among the conditions Dr. Vipani treats.

CMS data shows 315 Medicare services from Dr. Vipani across 9 procedure codes in 2024, for 206 Medicare patients. Medicare paid $26,566 for them.

CMS counts 206 Medicare patients who saw Dr. Vipani in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 3.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vipani's median patient age at 64, with 51% women.

In 2024, Dr. Vipani wrote 166 Medicare Part D claims for 44 patients. 75% of them were for generic drugs. CMS names the drug for 103 of them, across 7 drugs with 11 or more claims each, at $92,452 in total drug cost. In 2023, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Vipani for performance year 2024, reported as part of a group. Dr. Vipani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vipani as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Vipani, published from 2014 to 2025. 2021 was the busiest year, with 4. Dr. Vipani has published most often in ACG Case Rep J. Dr. Vipani's most frequent co-authors are Hirsh Divyang Trivedi, MD, Walid S. Ayoub, MD and Alexander Kuo, MD.

CMS Open Payments shows 14 general payments to Dr. Vipani from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Madrigal Pharmaceuticals paid the most, $383.

Dmand AI lists 3 awards for Dr. Vipani, most recently Leo Rigler, MD, Award for Academic Achievement in 2019.

Dr. Vipani graduated from Albany Medical College in 2016. Dr. Vipani is a member of ACG, AGA and AMA.

Dr. Vipani is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.